EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycobiology of IgE

Aron Gyorgypal iD, Sayantan Banerjee, Michelle E Conroy, Robert M Anthony iD

Immunological Reviews · 2025

DOI: 10.1111/imr.70032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2025. Verfasst von Aron Gyorgypal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Allergy and Immunology, Department of Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hosp…. Hauptthemen laut MEDLINE: Immunoglobulin E, Polysaccharides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies play a vital role in the immune system, with distinct isotypes having unique tropisms and performing specialized functions. Of these isotypes, IgE is the least abundant in circulation yet plays a critical role in defense against parasitic infection and allergic reactions. IgE is also heavily N‐linked glycosylated, a posttranslational modification that influences receptor interactions of effector responses. The importance of glycosylation on IgG function is well established, and the roles of IgE glycans are emerging. This review examines the relationship between IgE glycosylation and its biological function. IgE glycosylation, specifically the oligomannosidic glycan, is necessary for IgE binding to its high‐affinity receptor FcεRI on mast cells and basophils. Recent evidence suggests that terminal sialic acid residues on complex biantennary glycans significantly enhance IgE's allergic potential, with sialylation of IgE demonstrating reduced capacity to trigger degranulation and anaphylaxis. Glycosylation also influences IgE's interaction with its low‐affinity receptor FcεRII/CD23, affecting serum clearance and antigen presentation. Beyond allergy, this review also covers IgE's impacts on its roles in autoimmunity, parasite defense, and protection against venoms. Current therapeutic approaches targeting IgE include monoclonal antibodies like omalizumab, with emerging therapeutics looking to target systemic IgE production mechanisms also covered. Although the understanding of IgG glycosylation is known, there is much to uncover in terms of IgE glycosylation, which may open new avenues for developing more precise interventions that modulate its effector functions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin EPolysaccharidesHumansAnimalsGlycosylationReceptors, IgEGlycomicsHypersensitivityMast CellsAutoimmunity

Stichwörter der Autor:innen

allergyasthmaimmune‐mediated diseasesinfectious diseasesparasitic‐helminthprocesses

Substanzen

Immunoglobulin EReceptors, IgEPolysaccharides

Autor:innen und Institutionen

  • Division of Rheumatology, Allergy and Immunology, Department of Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Aron Gyorgypal, Robert M Anthony

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Food Allergy Science Initiative

Zitieren

APA

Gyorgypal, A., Banerjee, S., Conroy, M. E., & Anthony, R. M. (2025). Glycobiology of IgE. Immunological Reviews. https://doi.org/10.1111/imr.70032

Vancouver

Gyorgypal A, Banerjee S, Conroy ME, Anthony RM. Glycobiology of IgE. Immunological Reviews. 2025. doi:10.1111/imr.70032

BibTeX
@article{Gyorgypal2025,
  author = {Gyorgypal, Aron and Banerjee, Sayantan and Conroy, Michelle E and Anthony, Robert M},
  title = {Glycobiology of IgE},
  journal = {Immunological Reviews},
  year = {2025},
  doi = {10.1111/imr.70032}
}
Kostenlos starten →